NVO   $126.82  -5.98% Market Open

Novo Nordisk A/S
Total Cash 62.65B
totalCashPerShare 14.055
EBITDA 126.56B
Total Debt 57.06B
quickRatio 0.739
currentRatio 0.945
Total Revenue 258.00B
debtToEquity 50.71
Revenue/Share 57.802
ROA 0.22798
ROE 0.88572
grossProfits
freeCashflow 54.49B
operatingCashflow 115.33B
earningsGrowth 0.04
revenueGrowth 0.253
grossMargins 0.84528
ebitdaMargins 0.49054
operatingMargins 0.4648
profitMargins 0.34844002
enterpriseValue 605.11B
forwardPE 31.786543
floatShares 3.18B
sharesOutstanding 3.38B
sharesShort 5.13M
sharesShortPriorMonth 4.05M
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.10%
Short Ratio help_outline 1.25%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 25.242
Price To Book help_outline 5.43
earningsQuarterlyGrowth 0.03
netIncomeToCommon 89.90B
trailingEps 2.96%
forwardEps 4.31%
enterpriseToEbitda 4.78
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.9 3Q 2024
institutionsCount 2109
lastUpdated Sept. 16, 2024, 11:38 a.m.